Our results show the expression of ICAM-1 at the mRNA level in cultured primary melanoma and cell lines, as well as in melanocytes, is heterogeneous with no significant difference in ICAM-1 expression between benign and malignant lesions (Figure 1). Here, ICAM1 is linked to melanoma.